Inhibition of choroidal neovascularization by topical application of angiogenesis inhibitor vasostatin

NCU Institutional Repository > 工學院 > 機械工程研究所 > 期刊論文 > Item 987654321/26869

jsp.display-item.identifier=請使用永久網址來引用或連結此文件: http://ir.lib.ncu.edu.tw/handle/987654321/26869

题名:	Inhibition of choroidal neovascularization by topical application of angiogenesis inhibitor vasostatin
作者:	Sheu,SJ;Bee,YS;Ma,YL;Liu,GS;Lin,HC;Yeh,TL;Liou,JC;Tai,MH
贡献者:	機械工程研究所
关键词:	INTRAVITREAL BEVACIZUMAB AVASTIN;MACULAR DEGENERATION;DRUG-DELIVERY;TUMOR-GROWTH;RANIBIZUMAB;SUPPRESSION;FRAGMENT;THERAPY;CALRETICULIN;ANTIBODY
日期:	2009
上传时间:	2010-06-29 18:02:05 (UTC+8)
出版者:	中央大學
摘要:	Purpose: Choroidal neovascularization (CNV) is the leading cause of blindness in patients with age-related macular degeneration (AMD). This study evaluated the inhibitory effect of vasostatin (VS), an endogenous angiogenesis inhibitor, on CNV. Methods: Anti-angiogenic activity of VS was evaluated in vitro by migration and tube formation assays in human umbilical vein endothelial cells (HUVECs). CNV lesions were induced in Brown Norway rats by fundus argon laser photocoagulation. Beginning one day after CNV induction, rats were treated with eye drops containing 1 mu g/ml VS in PBS buffer for three times daily for 20 days. The extent of CNV was examined by flat mount analysis on day 24 or by fundus fluorescein angiography (FAG) on days 21, 28, 35, and 42, respectively. CNV lesions and choroidal vascularity were evaluated by histological analysis. The spatial distribution of topically applied VS in rat eyes was evaluated by immunoblot analysis. Results: VS inhibited migration and tube formation in HUVECs. Flat mount analysis revealed that, after laser-induced photocoagulation, topical VS application for 20 days significantly reduced CNV lesions. Moreover, serial FAG analysis indicated that a 20 day VS treatment significantly reduced CNV lesions on all subsequent days. Histological analysis revealed attenuated lesions, intact Bruch's membrane, and reduced choroidal vascularity in VS-treated eyes. Finally immunoblot analysis reveled VS expression in choroids. Conclusions: Topical VS application suppresses the progression of laser-induced CNV via angiogenesis inhibition and may constitute a therapeutic alternative for excessive neovascularization occurring with ocular diseases.
關聯:	MOLECULAR VISION
显示于类别:	[機械工程研究所] 期刊論文

文件中的档案:

档案	描述	大小	格式	浏览次数
index.html		0Kb	HTML	444	检视/开启

在NCUIR中所有的数据项都受到原著作权保护.

社群 sharing

数据加载中.....